To read the full story, subscribe or sign in.

Shanghai Synergy initiates phase I/II study in China with hypidone in major depressive disorder

Feb. 5, 2018

BioWorld Science Neurology/psychiatric

Today's news in brief

BioWorld

BioWorld briefs for Nov. 4, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Nov. 4, 2025.

Tulyp emerges from stealth with pressure-driven perfusion system

BioWorld MedTech

Tulyp Medical Inc. has emerged from stealth mode with a pressure-driven perfusion system designed to improve vascular procedures. The company, born out of...

Illustration of nasopharyngeal carcinoma

Lepu’s MRG-003 cleared as China’s first EGFR ADC for advanced NPC

BioWorld

Lepu Biopharma Co. Ltd. said Oct. 30 it won Chinese approval of a novel antibody-drug conjugate (ADC), Meiyouheng (becotatug vedotin injection), making it China’s...

Illustration of magnifying glass inspecting brain

Anchoring, and bootstrapping, psychiatry into the precision medicine era

BioWorld Science

Psychiatry has struggled to enter the precision medicine era. But through a mix of innovations and bootstrapping, progress is coming to the field. Scientists are...